查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太地區DNA甲基化檢測技術市場：分析與預測（2023-2033）
市場調查報告書
商品編碼
1556452

亞太地區DNA甲基化檢測技術市場：分析與預測（2023-2033）

Asia-Pacific DNA Methylation Detection Technology Market: Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 58 Pages | 商品交期: 1-5個工作天內

價格

2023年亞太地區DNA甲基化檢測技術市場規模為4.436億美元。

預計2023年至2033年該市場將以17.79%的複合年成長率成長，2033年達到22.806億美元。這一成長可歸因於生物技術和製藥行業新興企業數量的增加、學術機構之間合作的加強以及 DNA 甲基化檢測技術作為表觀遺傳生物標記的廣泛使用。市場提供各種工具、軟體和消耗品。

主要市場統計數據
預測期 2023-2033
2023年評估 4.436 億美元
2033 年預測 22.806 億美元
複合年成長率 17.79%

由於該領域對個人化醫療和前沿基因組研究的需求不斷成長，亞太地區DNA甲基化檢測技術市場正在迅速擴大。 DNA甲基化是與癌症、神經系統疾病和心血管疾病等許多疾病相關的重要表觀遺傳修飾之一。 DNA 甲基化對於控制基因表現至關重要。隨著表觀遺傳學在疾病診斷和治療中的作用日益明確，人們越來越需要準確有效的DNA甲基化檢測技術。

公共和商業部門都在大力資助與精準醫學和基因組學相關的工作，尤其是在韓國、中國和日本等國家。此外，該地區慢性病的高發生率增加了對早期檢測和標靶治療的需求，進一步推動了DNA甲基化技術的採用。

隨著次世代定序(NGS) 和高通量平台等技術的發展，DNA 甲基化分析的準確性和速度正在提高，學術機構和醫療專業人員也越來越負擔得起。隨著亞太地區成為生物醫學創新中心，DNA 甲基化檢測技術市場預計將顯著成長。這對於個人化醫療的進步和改善患者的治療效果至關重要。

本報告考察了亞太地區 DNA 甲基化檢測技術市場，提供了市場概述、區域趨勢以及參與該市場的公司概況。

目錄

執行摘要

第1章 市場

  • 趨勢：當前和未來的影響評估
  • 供應鏈概覽
  • 研究發展回顧
  • 監管狀況
  • 全球重大事件的影響分析 - COVID-19
  • 市場動態概覽

第2章 區域

  • 區域概況
  • 促進因素和抑制因素
  • 亞太地區

第3章市場－競爭基準化分析與公司概況

  • 未來展望
  • 地理評估
    • Takara Bio Inc.

第4章調查方法

Product Code: BHP2267SS

Introduction to Asia-Pacific (APAC) DNA Methylation Detection Technology Market

The Asia-Pacific DNA methylation detection technology market was valued at $443.6 million in 2023 and is expected to reach $2,280.6 million by 2033, growing at a CAGR of 17.79% between 2023 and 2033. This growth can be ascribed to rising startups in the biotechnology and pharmaceutical industries, growing collaborations between academic institutions, and the growing use of DNA methylation detection technology as epigenetic biomarkers. The market offers a range of tools, software, and consumables.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$443.6 Million
2033 Forecast$2,280.6 Million
CAGR17.79%

The market for DNA methylation detection technologies in Asia-Pacific is expanding rapidly due to the rising demand for personalized medicine and cutting-edge genomic research in the area. One important epigenetic modification that is linked to a number of diseases, including cancer, neurological disorders, and cardiovascular conditions, is DNA methylation. It is essential for regulating gene expression. Accurate and effective DNA methylation detection technologies are becoming more and more in demand as the role of epigenetics in disease diagnosis and treatment becomes increasingly clear.

Growing investments in biomedical research are driving the market's growth, especially in nations like South Korea, China, and Japan where both the public and commercial sectors are heavily funding efforts related to precision medicine and genomics. Furthermore, the region's high rate of chronic illnesses is increasing the demand for early detection and targeted therapies, further boosting the adoption of DNA methylation technologies.

The precision and speed of DNA methylation analysis are being improved by technological developments like next-generation sequencing (NGS) and high-throughput platforms, which are also making these technologies more affordable for academic institutions and medical professionals. The market for DNA methylation detection technology is expected to grow significantly as APAC establishes itself as a center for biomedical innovation. This will be crucial for the advancement of personalized medicine and better patient outcomes.

Market Segmentation

Segmentation 1: by Contry

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Growth/Marketing Strategy: A strategic growth and marketing approach for the APAC DNA methylation detection technology market would involve positioning the company as a leader in innovative solutions that address the evolving needs of researchers, clinicians, and pharmaceutical partners. This would entail leveraging technological advancements to develop cutting-edge products with enhanced sensitivity, specificity, and scalability while also investing in comprehensive customer support, training programs, and collaborative partnerships to foster customer loyalty and drive market penetration. Furthermore, targeted marketing campaigns highlighting the clinical relevance, cost-effectiveness, and competitive advantages of the company's offerings would help to increase brand visibility, attract new customers, and expand market share in this rapidly growing and dynamic industry.

Competitive Strategy: Key players in the APAC DNA methylation detection technology market have been focusing on innovation, differentiation, and strategic collaborations to gain a competitive edge. By investing in research and development, companies can develop novel detection methods, improve assay sensitivity, and expand application areas. Differentiation through the development of proprietary technologies, customizable solutions, and value-added services can help companies stand out in a crowded market, strengthen market positions, acquire new technologies, and broaden product portfolios.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Key Trends
    • 1.1.2 Bisulfite Conversion as a Gold Standard in the DNA Methylation Detection Technology Market
    • 1.1.3 Expansion of DNA Methylation Detection Technology in Clinical Research Applications
  • 1.2 Supply Chain Overview
    • 1.2.1 Value Chain Analysis
    • 1.2.2 Market Map
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Company)
  • 1.4 Regulatory Landscape
  • 1.5 Impact Analysis for Key Global Events - COVID-19
  • 1.6 Market Dynamics Overview
    • 1.6.1 Market Drivers
      • 1.6.1.1 Increasing Adoption of DNA Methylation Detection Technology as Epigenetic Biomarkers
      • 1.6.1.2 Increasing Research and Development in Genomics and Epigenetics
      • 1.6.1.3 Technological Advancements in Detection Methods
    • 1.6.2 Market Restraints
      • 1.6.2.1 Complexity in Data Interpretation of DNA Methylation Data
      • 1.6.2.2 High Cost of DNA Methylation Detection Instruments and Various Kits and Assays
    • 1.6.3 Market Opportunities
      • 1.6.3.1 DNA Methylation Detection Technology as an Early Disease Diagnostic Tool
      • 1.6.3.2 Expansion of DNA Methylation Detection in Emerging Geographies

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Asia-Pacific
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 China
    • 2.3.5 Japan
    • 2.3.6 India
    • 2.3.7 Australia
    • 2.3.8 South Korea
    • 2.3.9 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Next Frontiers
  • 3.2 Geographic Assessment
    • 3.2.1 Takara Bio Inc.
      • 3.2.1.1 Overview
      • 3.2.1.2 Top Products/Product Portfolio
      • 3.2.1.3 Top Competitors
      • 3.2.1.4 Key Personnel
      • 3.2.1.5 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: DNA Methylation Detection Technology Market (by Region), $Billion, 2022, 2026, and 2033
  • Figure 2: Number of Methylation Analysis Publications, in Thousands, 2002-2020
  • Figure 3: Number of Commercially Available Methylation Tests (by Application Areas)
  • Figure 4: DNA Methylation Detection Technology Market, Recent Developments
  • Figure 5: Supply Chain and Risks within the Supply Chain
  • Figure 6: DNA Methylation Detection Technology Market (by Country), January 2021-December 2023
  • Figure 7: DNA Methylation Detection Technology Market (by Year), January 2021-December 2023
  • Figure 8: Impact of COVID-19 on DNA Methylation Detection Technology
  • Figure 9: Impact Analysis of Market Navigating Factors, 2022-2033
  • Figure 10: Advantage of DNA Methylation as Epigenetic Biomarkers
  • Figure 11: Analyzing the Differences: IColocomf vs. FIT and Colonoscopy
  • Figure 12: Evolution in Next-Generation Sequencing (NGS)Techniques for DNA Methylation Analysis, 2005-2021
  • Figure 13: Factors Responsible for Complexity in Data Interpretation
  • Figure 14: Pricing Analysis of Major DNA Methylation Detection Kits and Assays
  • Figure 15: Startups Working in Epigenomics Research
  • Figure 16: China DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 17: Japan DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 18: Australia DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 19: South Korea DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 20: Rest-of-Asia-Pacific DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 21: Strategic Initiatives, 2019-2023
  • Figure 22: Share of Strategic Initiatives, 2019-2023
  • Figure 23: Data Triangulation
  • Figure 24: Top-Down and Bottom-Up Approach
  • Figure 25: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: DNA Methylation Detection Technology Market, Opportunities
  • Table 3: Market Share of Key Companies, 2022
  • Table 4: DNA Methylation Detection Technology Market, Product Benchmarking
  • Table 5: Examples of Increasing Research in the DNA Methylation Detection Technology Industry
  • Table 6: Key Companies and Technological Advancements, 2019-2023
  • Table 7: DNA Methylation Detection Technology Market (by Region), $Million, 2022-2033
  • Table 8: India DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Table 9: Company Market Share, 2022